DSP Healthcare Fund

Regular Plan · IDCW · Sectoral / Thematic · Scheme code 145453

NAV₹25.9260as on 29 Oct 2026

Fund houseDSP Mutual Fund

CategorySectoral / Thematic

Plan & optionRegular · IDCW

History7.7 years

Returns (%)

	1M	3M	6M	1Y	3Y	5Y	7Y	10Y	Launch
This scheme	3.66	12.71	20.74	8.36	11.33	5.09	15.50	—	13.43
Nifty 500 benchmark	0.87	4.31	2.15	5.20	12.49	11.41	—	—	15.49
Sectoral / Thematic category median	—	—	—	-6.58	11.54	8.85	—	12.68	—

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

	Volatility	Sharpe	Sortino	Beta	Alpha	Max fall	R²
This scheme	18.4%	0.26	0.37	0.80	0.02%	-29.5%	44.11
Nifty 500 benchmark	15.2%	0.39	0.58	—	—	-37.3%	—

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 36 months this scheme and its benchmark share.

Growth of ₹100 since launch

Drawdown from peak (%)

Every one-year period it has lived through

Windows	Worst	Median	Best	Periods that lost money
1,642	-23.3%	11.6%	94.1%	31%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

How it behaves against its benchmark

Up capture	Down capture	Correlation	Tracking error	Information ratio	Treynor
84%	74%	0.66	14.1%	-0.08	5.91

Up capture is how much of the benchmark's gain this scheme kept in the months the benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it on the up side is the combination every fund is trying for and few reach. Measured over the 36 months this scheme and Nifty 500 share.

DSP Healthcare Fund

Regular Plan · IDCW

Allocation

By asset

Equity	83.95%
Foreign Securities	9.31%
Cash & Equivalents	6.74%

By market cap

Large Cap	24.86%
Mid Cap	14.16%
Small Cap	42.73%
Unclassified	11.51%

Concentration

Number of stocks	32
Top 5 stocks	35.42%
Top 10 stocks	59.35%
Top 20 stocks	83.47%
Lines in the filing	34

Largest holding	8.13%
Largest sector	Pharmaceuticals & Biotechnology 65.75%
Effective stocks	22.7
Sectors held	5
Cash	6.74%

Effective stocks is what the concentration works out to: a fund holding 32 names but most of its money in a few behaves like a fund of 23. Cash includes repo and TREPS, which every fund parks money in overnight.

Sector split

Pharmaceuticals & Biotechnology	65.75%
Healthcare Services	17.84%
Healthcare Equipment & Supplies	7.55%
Cash & Equivalents	6.74%
Foreign Security	1.10%
Insurance	1.02%

DSP Healthcare Fund

Regular Plan · IDCW · holdings

Top 30 holdings

#	Company	Sector	Shares held	Value ₹ cr	% of fund
1	IPCA Laboratories Limited	Pharmaceuticals & Biotechnology	1,582,807	305	8.13%
2	Sun Pharmaceutical Industries Limited	Pharmaceuticals & Biotechnology	1,535,592	279	7.44%
3	Cipla Limited	Pharmaceuticals & Biotechnology	2,001,379	269	7.18%
4	TREPS / Reverse Repo Investments	Unclassified	—	255	6.81%
5	Sai Life Sciences Limited	Pharmaceuticals & Biotechnology	1,602,712	244	6.52%
6	Gland Pharma Limited	Pharmaceuticals & Biotechnology	795,267	231	6.15%
7	Apollo Hospitals Enterprise Limited	Healthcare Services	278,729	228	6.07%
8	Globus Medical Inc	Healthcare Equipment & Supplies	268,800	193	5.15%
9	Alkem Laboratories Limited	Pharmaceuticals & Biotechnology	344,654	178	4.75%
10	Divi's Laboratories Limited	Pharmaceuticals & Biotechnology	168,223	156	4.17%
11	Cohance Lifesciences Limited	Pharmaceuticals & Biotechnology	3,202,999	142	3.79%
12	Alembic Pharmaceuticals Limited	Pharmaceuticals & Biotechnology	1,442,516	119	3.18%
13	Kovai Medical Center And Hospital Limited	Healthcare Services	176,815	106	2.83%
14	Pfizer Limited	Pharmaceuticals & Biotechnology	263,627	102	2.72%
15	Concord Biotech Limited	Pharmaceuticals & Biotechnology	735,820	101	2.70%
16	Vijaya Diagnostic Centre Limited	Healthcare Services	615,708	89	2.36%
17	Procter & Gamble Health Limited	Pharmaceuticals & Biotechnology	159,288	89	2.36%
18	Indoco Remedies Limited	Pharmaceuticals & Biotechnology	3,245,682	85	2.26%
19	Intuitive Surgical Inc	Healthcare Equipment & Supplies	18,768	73	1.95%
20	Thyrocare Technologies Limited	Healthcare Services	1,341,127	72	1.91%
21	Manipal Health Enterprises Limited	Healthcare Services	980,058	69	1.85%
22	Unichem Laboratories Limited	Pharmaceuticals & Biotechnology	1,128,668	62	1.64%
23	Syngene International Limited	Healthcare Services	1,385,126	51	1.35%
24	Nephrocare Health Services Limited	Healthcare Services	634,983	42	1.12%
25	Global X Funds - Global X Genomics & Biotechnology ETF	Foreign Security	61,250	41	1.10%
26	ICICI Lombard General Insurance Co Limited	Insurance	241,413	38	1.02%
27	Aarti Drugs Limited	Pharmaceuticals & Biotechnology	852,155	37	0.98%
28	Abbott Laboratories	Pharmaceuticals & Biotechnology	31,600	30	0.80%
29	Eris Lifesciences Limited	Pharmaceuticals & Biotechnology	225,856	27	0.72%
30	Jupiter Life Line Hospitals Limited	Healthcare Services	516,535	13	0.35%

DSP Healthcare Fund

Regular Plan · IDCW · where the money sits

What the manager did last month

Between the filings of 30 Jun 2026 and 31 Jul 2026. A position grows because the manager bought or because the price rose; only the share count separates them.

Bought	Sold	New positions	Sold out of	Price move of holdings
₹120 cr	₹0 cr	4	3	+1.95%

Stock	Shares traded	Shares	Price	Value ₹ cr
New position
Manipal Health Enterprises Ltd	1,859,425	entered	—	110
Divi's Laboratories Ltd	105,248	entered	—	84.8
Eris Lifesciences Ltd	225,856	entered	—	30.6
Jupiter Life Line Hospitals Ltd	516,535	entered	—	17.1
Added to
Alkem Laboratories Ltd	129,071	+78.3%	+3.3%	74.2
Apollo Hospitals Enterprise Ltd	40,665	+20.9%	+3.2%	36.4
Syngene International Ltd	142,391	+12.9%	-12.2%	5.5
Pfizer Ltd	5,034	+2.5%	+8.7%	2.4
Cohance Lifesciences Ltd	23,118	+0.7%	-6.8%	1.0
Unichem Laboratories Ltd	13,881	+1.3%	+11.2%	0.7
Sold out of
Illumina Inc	160,400	exited	—	267
Jupiter Life Line Hospitals Limited	94,117	exited	—	13.4
Emcure Pharmaceuticals Limited	69,966	exited	—	12.9

Not equity	Previous filing	This filing	Change
Cash, repo and TREPS	₹0 cr	₹0 cr	+₹0 cr

The list above is stocks and fund units. Treasury bills, repo and money-market lines roll over every month by design — they are not decisions, so they are totalled here rather than listed as activity.

A ₹10,000 monthly SIP over five years

Invested	Value	Gain	XIRR
₹600,000	₹762,077	₹162,077	9.51%

XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has been invested for a different length of time.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 1 Nov 2026.